AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹283 Cr | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr |
What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹283 Cr |
Mar2024 | ₹226 Cr |
Mar2023 | ₹173 Cr |
Mar2022 | ₹172 Cr |
Mar2021 | ₹157 Cr |
How is Long Term Provisions of AUROBINDO PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹283 Cr | 25.36 | |
Mar2024 | ₹226 Cr | 30.67 | |
Mar2023 | ₹173 Cr | 0.54 | |
Mar2022 | ₹172 Cr | 9.34 | |
Mar2021 | ₹157 Cr | - |
Compare Long Term Provisions of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,809.6 Cr | 5.2% | 3.5% | -26.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,469.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,672.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹125,034.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,542.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,571.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 5.2% |
3.5% |
-26.9% |
SENSEX | 1.2% |
1.9% |
-0.2% |
You may also like the below Video Courses